Amarin Corp Plc (AMRN)

[alm2]

I agree as to the point you make relative to the 6 months generic benefit of filing ANDA ...and thus the race between generics to do so - but there is a huge difference between the taking of that Administrative step and the investment involved in getting the product to launch point - it’s a commercial decision -does a generic spend all those bucks on taking those further steps -only to find that within a few months they lose appeal and can not launch and thus have wasted all the money involved - or are stopped by injunction - or do so but lose appeal and have to pay significant damages
I suspect Amarin consider it most unlikely indeed any launch by generic before appeal
Alm